Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
05/2010
05/20/2010WO2010055139A1 Process for manufacturing substituted 3-pyridylmethyl ammonium bromides
05/20/2010WO2010055042A1 2-[(1-cyanopropyl)carbamoyl]-5-methoxymethyl nicotinic acids and the use thereof in manufacturing herbicidal imidazolinones
05/20/2010WO2010055006A1 Naphthylacetic acids used as crth2 antagonists or partial agonists
05/20/2010WO2010055004A1 Naphthylacetic acids
05/20/2010WO2010054954A1 Process for manufacturing 5-chloromethyl-2,3-pyridine dicarboxylic acid anhydrides
05/20/2010WO2010054952A1 2-[(1-cyanopropyl)carbamoyl]-5-chloromethyl nicotinic acids and the use thereof in manufacturing herbicidal imidazolinones
05/20/2010WO2010017094A3 CURCUMIN DERIVATIVES FOR AMYLOID-β PLAQUE IMAGING
05/20/2010US20100125138 PROCESS FOR MAKING (R)-3-(2,3-DIHYDROXYPROPYL)-6-FLUORO-5-(2-FLOURO-4-IODOPHENYLAMINO)-8-METHYLPYRIDO[2,3-d]PYRIMIDINE-4,7(3H,8H)-DIONE AND INTERMEDIATES THEREOF
05/20/2010US20100125090 Modulators of ATP-Binding Cassette Transporters
05/20/2010US20100125075 Antibacterial Agents
05/20/2010CA2742297A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010CA2740863A1 Naphthylacetic acids
05/20/2010CA2739725A1 Naphthylacetic acids used as crth2 antagonists or partial agonists
05/19/2010EP2186803A2 Substituted thioacetamides
05/19/2010EP2186802A1 Method for separating and purifying alpha -unsaturated amine compound
05/19/2010EP2185543A2 Method for splitting omeprazole salts
05/19/2010EP2185539A1 Viral polymerase inhibitors
05/19/2010EP2185516A2 Polymorphs of 3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)-phenoxy)-acetic acid sodium salt or a hydrate thereof and methods for making the same
05/19/2010EP2185515A2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
05/19/2010EP2185502A1 Pyridinecarboxamide and benzamide derivatives as taar1 ligands
05/19/2010EP2184987A1 Bi-dentate compounds as kinase inhibitors
05/19/2010EP1706372B1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
05/19/2010EP1685091B1 M-diaminobenzoles and the acidic adducts thereof and use thereof in colouring agents
05/19/2010EP1599467B1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
05/19/2010EP1575575B1 Safe chemical uncouplers for the treatment of obesity
05/19/2010CN1973625B Pyridyl quaternary ammonium salt antiseptic and its preparation process
05/19/2010CN101711237A azapeptide derivatives
05/19/2010CN101709099A Polymer containing pyridine ring and composition magnetic membrane material and preparation method thereof
05/19/2010CN101709052A Preparation method of 2-(3-trifluoromethyl phenoxy) niacin
05/19/2010CN101709051A Preparation method of 2-amino-3-chloro-5-(trifluoromethyl) pyridine
05/19/2010CN101709050A New method for synthesizing 2, 5-dichloropyridine
05/19/2010CN101107230B Process for production of 5-chloro-2,4-dihydroxypyridine
05/18/2010US7718807 3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one hydrochloride; for Parkinson's disease, having AMPA (alpha -amino-3-hydroxy-5-methyl-4-isooxazolepropionic acid) receptor antagonistic activity and/or kainic acid receptor inhibitory activity
05/18/2010US7718804 Quaternary nitrogen heterocyclic boronic acid-containing compounds sensitive to glucose and fructose; contact lens; radiometers; kits; ophthalmic sensors
05/18/2010US7718803 dispersion and storage stability; light resistance
05/18/2010US7718722 Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber
05/18/2010US7718702 Cannabinoid receptor ligands
05/18/2010US7718675 Diamino alcohols and their use as renin inhibitor
05/18/2010US7718671 Substituted small-molecule arylthiourea compounds are potent and/or selective inhibitors of viral replication in vivo, particularly Hepatitis C virus replication; e.g., 1-(3-benzyloxy)phenylthiourea; side effect reduction
05/18/2010US7718651 Inhibiting polymerization of FtsZ in a bacterium by contactng with 2,3-diphenyl-6-(ethoxycarbonylamino)-8-(4-(diethylamino)-1-methylbutylamino)pyrido[2,3-b]pyrazine, optionally linked to a permeability enhancer to allow the compound to cross the bacterium's cell envelope
05/14/2010WO2010053388A1 New 4,6-disubstituted 2-(4-methylpiperazin-1-yl)pyridine derivatives, a process for their preparation, pharmaceutical composition containing these compounds, their use, a method for modulating monoaminergic receptor activity and a monoaminergic receptor modulating agent
05/14/2010WO2010051926A2 New halogen-substituted bonds
05/14/2010WO2010033043A8 Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof
05/14/2010WO2010017343A3 Flupirtine hydrochloride maleic acid cocrystal
05/14/2010WO2009156484A3 Organic compounds
05/14/2010CA2742435A1 New halogen-substituted compounds
05/13/2010US20100121083 Anti-viral agent
05/13/2010US20100121069 Method for manufacturing a beta-diaryl electron withdrawing group substituted compound
05/13/2010US20100121062 Slow Release of Organoboronic Acids in Cross-Coupling Reactions
05/13/2010US20100121061 Compounds capable of activating cholinergic receptors
05/13/2010US20100121054 Process for producing substituted methylamine compound and triazine derivative
05/13/2010US20100120872 Organic compounds and their uses
05/13/2010US20100120862 Monocyclic compounds and their use as trpv1 ligands
05/13/2010US20100120845 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
05/12/2010EP2184280A1 Substituted oxyguanidines
05/12/2010EP2184273A1 Halogen substituted compounds as pesticides
05/12/2010EP2184073A1 Therapeutic agent for cancer with resistance to protease inhibitor
05/12/2010EP2183241A2 2-pyridine carboxamide derivatives as sodium channel modulators
05/12/2010EP2183215A2 Imidate compound and use thereof for pest control
05/12/2010EP2183213A2 Optically active (r)-aryloxypropionic acid amides and herbicidal composition comprising same
05/12/2010EP2182935A1 The use of benzamide derivatives for the treatment of cns disorders
05/12/2010EP2182808A1 Pyridine compounds for inflammation and immune-related uses
05/12/2010CN1972960B Processes for preparing eptifibatide
05/12/2010CN1933853B Drug conjugates
05/12/2010CN1919844B Method for aqueous phase oxo-synthesis of iansoprazole
05/12/2010CN1915976B Method for preparing 5- chlorine -4 hydroxy -2(1II)- pyridone and intermediate
05/12/2010CN1803795B Substituted piperidine compounds for use as h3 histamine receptor antagonists
05/12/2010CN1800174B Molecular switch crown ether-purple crystal quasirotaxane and its preparation method
05/12/2010CN1762957B 2,3-dihydro-1-indene compound and preparation method thereof
05/12/2010CN1751025B Diamine derivatives
05/12/2010CN1578557B Organometallic complex and organic electroluminescent device employing the same
05/12/2010CN101704810A Cycloalkyl inhibitors of potassium channel function
05/12/2010CN101704797A compounds effecting glucokinase
05/12/2010CN101704781A Preparation method of amino pyridine bromide compound
05/12/2010CN101704780A Aromatic sulfur acetyl pyridine derivative and preparation method and application thereof
05/12/2010CN101703501A Propargyl imine compounds and use thereof in preparation of MAO inhibitor
05/12/2010CN101113138B Method for synthesizing aryl radical nitrile derivant under catalysis of cyclopalladated ferrocenylimines complex
05/11/2010US7714170 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis
05/11/2010US7714138 Monocyclic heterocycles as kinase inhibitors
05/11/2010US7714004 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
05/11/2010US7714002 Carbocycle and heterocycle antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010CA2412968C Substituted pyridines as selective cyclooxygenase-2 inhibitors
05/11/2010CA2399089C Process for exchanging functional groups by halogen-metal exchange reaction
05/11/2010CA2248244C Heterocyclic aromatic anion salts, and their uses as ionic conducting materials
05/06/2010WO2010051236A1 Isonicotinamide orexin receptor antagonists
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010049768A1 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
05/06/2010WO2010049331A1 Heterocyclic antiviral arylpyridone derivatives
05/06/2010WO2010049302A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/06/2010WO2010048880A1 The nitropyridinyl ethyleneimine compound, the pharmaceutical composition containing it, the preparation method and use thereof
05/06/2010WO2009141241A3 Substituted pyridin-4-ylmethyl sulfonamides
05/06/2010US20100113770 O-substituted hydroxyaryl derivatives
05/06/2010US20100113536 haloalkylsulfone substituted compounds useful for treating obesity and diabetes
05/06/2010US20100113533 Polymorph II of 4-[4-(Amino)-3- Fluorophenoxy]-N-Methylpyridine-2-Carboxamide
05/06/2010US20100113523 Tryptase Enzyme Inhibiting Aminopyridines
05/06/2010US20100113522 COMPOUNDS FOR THE MODULATION OF PPARgamma ACTIVITY
05/06/2010US20100113511 Mono Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
05/06/2010US20100113477 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof
05/06/2010US20100113449 Fused heterocyclic compounds as ion channel modulators